Learn More
Description
A non-specific inhibitor of adenosine 3',5'-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3',5'-cyclic monophosphate.
- Inhibits phenylephrine-induced release of 5-hydroxytryptamine from neuroendocrine epithelial cells of the airway mucosa (IC50: 1.3μM)
- Serves as an adenosine receptor antagonist
- Inhibits ion channels in the neuromuscular junction, GH3 cells, and vascular smooth muscle cells
- Induces calcium release from intracellular stores in sensory neurons
- Inhibits the growth of carcinoma cells both in vivo and in vitro in mice
Specifications
Specifications
| Punto di fusione | 195°C to 202°C |
| Quantità | 250 mg |
| Peso formulazione | 222.25 |
| Forma fisica | Powder |
Safety and Handling
- 3-Isobutyl-1-methylxanthine
- Attenzione
- Tossicità acuta Categoria 4
- H302-Nocivo se ingerito.
- P264-Lavare accuratamente dopo l'uso.
- P270-Non mangiare, né bere, né fumare durante l'uso.
- P301+P312-IN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI/medico
- P330-Sciacquare la bocca.
- P501b-Smaltire il prodotto/recipiente in conformità con le disposizioni locali/regionali/nazionali/internazionali.
- MIXTURE LIST-Contain: 3-Isobutyl-1-methylxanthine
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.